R&D / revenue moved 321 bp lower
R&D / revenue changed -321 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
20.65%→17.44%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →YEXT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 1082 bp lower
Working capital / assets changed -1082 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
2.28%→-8.54%4 prior comparisons
Receivables / revenue moved 321 bp higher
Receivables / revenue changed +321 basis points from the comparable as-filed period.
58.72%→61.92%2 prior comparisons
SBC / revenue moved 250 bp lower
SBC / revenue changed -250 basis points from the comparable as-filed period.
11.46%→8.97%2 prior comparisons
Research & development decreased 17.0%
Research & development changed -17.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$23.4M→$19.4M2 prior comparisons
Current liabilities decreased 16.1%
Current liabilities changed -16.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$286.1M→$240.0M4 prior comparisons
Stock-based compensation decreased 23.2%
Stock-based compensation changed -23.2% from the comparable as-filed period.
$13.0M→$10.0M3 prior comparisons
Gross margin moved 27 bp higher
Gross margin changed +27 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
75.19%→75.46%2 prior comparisons
Capital expenditure decreased 54.8%
Capital expenditure changed -54.8% from the comparable as-filed period.
$573,000→$259,0003 prior comparisons
Revenue decreased 1.8%
Revenue changed -1.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$113.1M→$111.1M2 prior comparisons
Debt / assets moved 1483 bp higher
Debt / assets changed +1483 basis points from the comparable as-filed period.
15.70%→30.52%0 prior comparisons
Operating cash flow / net income increased 92.3%
Operating cash flow / net income changed +92.3% from the comparable as-filed period.
0.31→0.60 prior comparisons
Cash / debt moved 12310 bp lower
Cash / debt changed -12310 basis points from the comparable as-filed period.
181.89%→58.79%0 prior comparisons
Debt / revenue moved 4604 bp higher
Debt / revenue changed +4604 basis points from the comparable as-filed period.
86.90%→132.94%0 prior comparisons
Current ratio decreased 21.2%
Current ratio changed -21.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
1.05→0.834 prior comparisons
Operating cash flow decreased 5.5%
Operating cash flow changed -5.5% from the comparable as-filed period.
$8.4M→$7.9M3 prior comparisons
Free-cash-flow proxy decreased 1.9%
Free-cash-flow proxy changed -1.9% from the comparable as-filed period.
$7.8M→$7.7M3 prior comparisons
Net debt changed across a sign change
Net debt changed +175.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$80.5M→$60.9M0 prior comparisons
Capex / revenue moved 27 bp lower
Capex / revenue changed -27 basis points from the comparable as-filed period.
0.51%→0.23%2 prior comparisons
Gross profit decreased 1.4%
Gross profit changed -1.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$85.0M→$83.8M2 prior comparisons
Operating cash-flow margin moved 28 bp lower
Operating cash-flow margin changed -28 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
7.43%→7.15%2 prior comparisons
Free-cash-flow margin moved 1 bp lower
Free-cash-flow margin changed -1 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
6.93%→6.92%2 prior comparisons
Trade receivables increased 3.6%
Trade receivables changed +3.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$66.4M→$68.8M4 prior comparisons
Cash & equivalents decreased 20.1%
Cash & equivalents changed -20.1% from the comparable as-filed period.
$115.0M→$91.9M2 prior comparisons
SBC / revenue moved 226 bp lower
SBC / revenue changed -226 basis points from the comparable as-filed period.
11.56%→9.30%2 prior comparisons
Revenue decreased 1.4%
Revenue changed -1.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$109.5M→$107.9M3 prior comparisons
Stock-based compensation decreased 20.7%
Stock-based compensation changed -20.7% from the comparable as-filed period.
$12.7M→$10.0M3 prior comparisons
Free-cash-flow proxy decreased 0.4%
Free-cash-flow proxy changed -0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$37.2M→$37.0M6 prior comparisons
Operating cash flow decreased 0.8%
Operating cash flow changed -0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$37.7M→$37.4M6 prior comparisons
Capital expenditure decreased 23.7%
Capital expenditure changed -23.7% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
$562,000→$429,0006 prior comparisons
Research & development decreased 1.9%
Research & development changed -1.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$21.9M→$21.5M3 prior comparisons
Gross profit decreased 4.4%
Gross profit changed -4.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$82.4M→$78.7M3 prior comparisons
Capex / revenue moved 12 bp lower
Capex / revenue changed -12 basis points from the comparable as-filed period.
0.51%→0.40%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.